Production (Stage)
Rani Therapeutics Holdings, Inc.
RANI
$0.5289
-$0.031-5.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.26M | -8.95M | -6.78M | -6.81M | -7.48M |
| Total Depreciation and Amortization | 251.00K | 266.00K | 259.00K | 255.00K | 248.00K |
| Total Amortization of Deferred Charges | 58.00K | 58.00K | 58.00K | 58.00K | 58.00K |
| Total Other Non-Cash Items | -1.22M | 1.10M | -1.29M | -2.62M | -3.39M |
| Change in Net Operating Assets | 28.00K | -1.13M | -656.00K | 81.00K | 1.16M |
| Cash from Operations | -8.15M | -8.66M | -8.41M | -9.03M | -9.40M |
| Capital Expenditure | -51.00K | -31.00K | -125.00K | -94.00K | -18.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 18.28M | 2.55M | 594.00K | 6.62M | 10.31M |
| Cash from Investing | 18.23M | 2.52M | 469.00K | 6.53M | 10.29M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3.75M | -3.75M | -1.25M | -- | -- |
| Issuance of Common Stock | 42.00K | 9.38M | 8.97M | 165.00K | 121.00K |
| Repurchase of Common Stock | -23.00K | -9.00K | -14.00K | -24.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -3.73M | 5.62M | 7.70M | 141.00K | 121.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.35M | -515.00K | -237.00K | -2.36M | 1.01M |